Published in Curr Genet on December 19, 2003
Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog (2009) 1.47
Induction by hypoxia of heterologous-protein production with the KlPDC1 promoter in yeasts. Appl Environ Microbiol (2006) 0.86
Connection between the Rag4 glucose sensor and the KlRgt1 repressor in Kluyveromyces lactis. Genetics (2006) 0.86
Enolase and glycolytic flux play a role in the regulation of the glucose permease gene RAG1 of Kluyveromyces lactis. Genetics (2004) 0.86
Transcriptomic analysis of extensive changes in metabolic regulation in Kluyveromyces lactis strains. Eukaryot Cell (2006) 0.81
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics (1989) 105.30
Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene (1988) 42.65
Coordinate control of syntheses of ribosomal ribonucleic acid and ribosomal proteins during nutritional shift-up in Saccharomyces cerevisiae. Mol Cell Biol (1981) 16.51
PCR-synthesis of marker cassettes with long flanking homology regions for gene disruptions in S. cerevisiae. Yeast (1996) 8.45
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
An efficient transformation procedure enabling long-term storage of competent cells of various yeast genera. Yeast (1991) 3.41
The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation. EMBO J (1995) 2.39
The GCR1 gene encodes a positive transcriptional regulator of the enolase and glyceraldehyde-3-phosphate dehydrogenase gene families in Saccharomyces cerevisiae. Mol Cell Biol (1987) 2.14
The gcr (glycolysis regulation) mutation of Saccharomyces cerevisiae. J Biol Chem (1981) 2.07
RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars. Yeast (1989) 1.66
GCR1 of Saccharomyces cerevisiae encodes a DNA binding protein whose binding is abolished by mutations in the CTTCC sequence motif. Proc Natl Acad Sci U S A (1991) 1.45
Role of GCR2 in transcriptional activation of yeast glycolytic genes. Mol Cell Biol (1992) 1.42
The complete sequence of the 8.2 kb segment left of MAT on chromosome III reveals five ORFs, including a gene for a yeast ribokinase. Yeast (1991) 1.41
GCR1, a transcriptional activator in Saccharomyces cerevisiae, complexes with RAP1 and can function without its DNA binding domain. EMBO J (1993) 1.41
Control of glycolytic gene expression in the budding yeast (Saccharomyces cerevisiae). Curr Genet (1995) 1.35
Characterization of the DNA-binding activity of GCR1: in vivo evidence for two GCR1-binding sites in the upstream activating sequence of TPI of Saccharomyces cerevisiae. Mol Cell Biol (1992) 1.29
Efficient transcription of the glycolytic gene ADH1 and three translational component genes requires the GCR1 product, which can act through TUF/GRF/RAP binding sites. Mol Cell Biol (1990) 1.29
gcr2, a new mutation affecting glycolytic gene expression in Saccharomyces cerevisiae. Mol Cell Biol (1990) 1.28
Glucose transport in the yeast Kluyveromyces lactis. I. Properties of an inducible low-affinity glucose transporter gene. Mol Gen Genet (1992) 1.22
Low- and high-copy-number shuttle vectors for replication in the budding yeast Kluyveromyces lactis. Gene (1996) 1.20
Different internal metabolites trigger the induction of glycolytic gene expression in Saccharomyces cerevisiae. J Bacteriol (1995) 1.17
The hexokinase gene is required for transcriptional regulation of the glucose transporter gene RAG1 in Kluyveromyces lactis. Mol Cell Biol (1993) 1.16
Rap1p requires Gcr1p and Gcr2p homodimers to activate ribosomal protein and glycolytic genes, respectively. Genetics (2001) 1.16
Activation mechanism of the multifunctional transcription factor repressor-activator protein 1 (Rap1p). Mol Cell Biol (1996) 1.13
Glucose uptake in Kluyveromyces lactis: role of the HGT1 gene in glucose transport. J Bacteriol (1996) 1.12
The GCR1 requirement for yeast glycolytic gene expression is suppressed by dominant mutations in the SGC1 gene, which encodes a novel basic-helix-loop-helix protein. Mol Cell Biol (1995) 1.10
Regulation of primary carbon metabolism in Kluyveromyces lactis. Enzyme Microb Technol (2000) 1.07
Induction of pyruvate decarboxylase in glycolysis mutants of Saccharomyces cerevisiae correlates with the concentrations of three-carbon glycolytic metabolites. Arch Microbiol (1993) 1.04
RAG4 gene encodes a glucose sensor in Kluyveromyces lactis. Genetics (2001) 1.01
The Kluyveromyces lactis equivalent of casein kinase I is required for the transcription of the gene encoding the low-affinity glucose permease. Mol Gen Genet (1997) 1.01
The E-box DNA binding protein Sgc1p suppresses the gcr2 mutation, which is involved in transcriptional activation of glycolytic genes in Saccharomyces cerevisiae. FEBS Lett (1999) 0.97
A phosphoglucose isomerase gene is involved in the Rag phenotype of the yeast Kluyveromyces lactis. Mol Gen Genet (1991) 0.95
Genomic exploration of the hemiascomycetous yeasts: 11. Kluyveromyces lactis. FEBS Lett (2000) 0.94
Understanding the growth phenotype of the yeast gcr1 mutant in terms of global genomic expression patterns. J Bacteriol (2000) 0.94
Signalling pathways leading to transcriptional regulation of genes involved in the activation of glycolysis in yeast. Mol Microbiol (1997) 0.91
Regulation of glycolysis by casein kinase I (Rag8p) in Kluyveromyces lactis involves a DNA-binding protein, Sck1p, a homologue of Sgc1p of Saccharomyces cerevisiae. Curr Genet (2002) 0.84
Transcription of the HXT4 gene is regulated by Gcr1p and Gcr2p in the yeast S. cerevisiae. Yeast (1999) 0.77
Altered response to growth rate changes in Kluyveromyces lactis versus Saccharomyces cerevisiae as demonstrated by heterologous expression of ribosomal protein 59 (CRY1) Nucleic Acids Res (1991) 0.76
Isolation of GCR1, a major transcription factor of glycolytic genes in Saccharomyces cerevisiae, from Kluyveromyces lactis. Yeast (2001) 0.76
Genomic exploration of the hemiascomycetous yeasts: 1. A set of yeast species for molecular evolution studies. FEBS Lett (2000) 3.71
Modulation of the Escherichia coli sigmaE (RpoE) heat-shock transcription-factor activity by the RseA, RseB and RseC proteins. Mol Microbiol (1997) 3.51
Data from amplified fragment length polymorphism (AFLP) markers show indication of size homoplasy and of a relationship between degree of homoplasy and fragment size. Mol Ecol (2002) 3.38
The cellulosome: an exocellular, multiprotein complex specialized in cellulose degradation. Crit Rev Biochem Mol Biol (1996) 2.36
Genomic exploration of the hemiascomycetous yeasts: 4. The genome of Saccharomyces cerevisiae revisited. FEBS Lett (2000) 2.14
Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. Nucleic Acids Res (2000) 2.13
Recognition specificity of the duplicated segments present in Clostridium thermocellum endoglucanase CelD and in the cellulosome-integrating protein CipA. J Bacteriol (1994) 2.12
Nitrogen-containing ligands for asymmetric homogeneous and heterogeneous catalysis. Chem Rev (2000) 1.83
Intravenous cyclosporine kinetics in renal failure. Clin Pharmacol Ther (1983) 1.73
Genomic exploration of the hemiascomycetous yeasts: 18. Comparative analysis of chromosome maps and synteny with Saccharomyces cerevisiae. FEBS Lett (2000) 1.69
Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol (1982) 1.65
Acidosis in a patient with cholera: a need to redefine concepts. QJM (2004) 1.47
Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development. J Pharmacokinet Biopharm (1995) 1.47
Subcellular localization of Clostridium thermocellum ORF3p, a protein carrying a receptor for the docking sequence borne by the catalytic components of the cellulosome. J Bacteriol (1994) 1.47
Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc (1986) 1.42
Diffuse small intestinal lymphoid infiltration in nonimmunodeficient adults from Western Europe. Gastroenterology (1988) 1.40
Functions of S-layers. FEMS Microbiol Rev (1997) 1.38
Glucose transport in the yeast Kluyveromyces lactis. II. Transcriptional regulation of the glucose transporter gene RAG1. Mol Gen Genet (1992) 1.32
Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci U S A (1993) 1.25
The 'petite-negative' yeast Kluyveromyces lactis has a single gene expressing pyruvate decarboxylase activity. Mol Microbiol (1996) 1.21
Genomic exploration of the hemiascomycetous yeasts: 20. Evolution of gene redundancy compared to Saccharomyces cerevisiae. FEBS Lett (2000) 1.18
Genomic exploration of the hemiascomycetous yeasts: 19. Ascomycetes-specific genes. FEBS Lett (2000) 1.16
Comparative pathogenesis of acute and latent infections of calves with bovine herpesvirus types 1 and 5. Arch Virol (2001) 1.16
Glucose uptake in Kluyveromyces lactis: role of the HGT1 gene in glucose transport. J Bacteriol (1996) 1.12
A single point mutation in TFIIA suppresses NC2 requirement in vivo. EMBO J (2000) 1.10
The Kluyveromyces lactis KEX1 gene encodes a subtilisin-type serine proteinase. FEBS Lett (1988) 1.09
[Chromosome aberrations produced in human lymphocytes by in vivo and in vitro irradiation]. C R Seances Soc Biol Fil (1985) 1.08
Genomic exploration of the hemiascomycetous yeasts: 3. Methods and strategies used for sequence analysis and annotation. FEBS Lett (2000) 1.06
In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm Res (1998) 1.05
Comparison of plasma extraction techniques in preparation of samples for endotoxin testing by the Limulus amoebocyte lysate test. J Clin Microbiol (1980) 1.01
RAG4 gene encodes a glucose sensor in Kluyveromyces lactis. Genetics (2001) 1.01
The Kluyveromyces lactis equivalent of casein kinase I is required for the transcription of the gene encoding the low-affinity glucose permease. Mol Gen Genet (1997) 1.01
Genomic exploration of the hemiascomycetous yeasts: 21. Comparative functional classification of genes. FEBS Lett (2000) 0.99
Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc Natl Acad Sci U S A (1997) 0.99
Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab Dispos (1999) 0.98
The role of the entorhinal cortex in two forms of spatial learning and memory. Exp Brain Res (2001) 0.97
Pharmacologic aspects of cyclosporine therapy: pharmacokinetics. Transplant Proc (1985) 0.96
The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. Leukemia (2009) 0.96
A phosphoglucose isomerase gene is involved in the Rag phenotype of the yeast Kluyveromyces lactis. Mol Gen Genet (1991) 0.95
Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial. J Clin Oncol (1993) 0.95
Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther (1994) 0.94
Selective cytotoxic lesions of the retrohippocampal region produce a mild deficit in social recognition memory. Exp Brain Res (2001) 0.94
Genomic exploration of the hemiascomycetous yeasts: 11. Kluyveromyces lactis. FEBS Lett (2000) 0.94
Sleep spindle activity changes in patients with affective disorders. Sleep (1987) 0.94
Influence of plasma protein binding on the brain uptake of an antifungal agent, terbinafine, in rats. J Pharm Pharmacol (1989) 0.93
A gene-cloning system for Kluyveromyces lactis and isolation of a chromosomal gene required for killer toxin production. J Basic Microbiol (1988) 0.93
Bacterial cellulases. Biochem Soc Trans (1992) 0.92
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol (1995) 0.91
Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J Neurochem (1996) 0.91
Apparent dose-dependent oral absorption of cyclosporin A in rats. Biopharm Drug Dispos (1984) 0.91
[Plastic repair with fascia lata for old tears of the anterior cruciate ligament (author's transl)]. Rev Chir Orthop Reparatrice Appar Mot (1981) 0.90
RAG3 gene and transcriptional regulation of the pyruvate decarboxylase gene in Kluyveromyces lactis. Mol Microbiol (1996) 0.90
Cytotoxic lesions of the hippocampus increase social investigation but do not impair social-recognition memory. Exp Brain Res (2001) 0.90
The respiratory system of Kluyveromyces lactis escapes from HAP2 control. Gene (1995) 0.90
Malignant lymphoma of the small bowel associated with diffuse nodular lymphoid hyperplasia. N Engl J Med (1985) 0.90
Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125. J Pharmacokinet Biopharm (1994) 0.89
P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther (1997) 0.89
Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol (1986) 0.88
A specific PCR to differentiate between gE negative vaccine and wildtype bovine herpesvirus type 1 strains. Vet Microbiol (1999) 0.87
Noble gas (argon and xenon)-saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation. Nephron Extra (2012) 0.86
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models. J Med Chem (1998) 0.85
Assessment of cyclosporine A interactions with human plasma lipoproteins in vitro and in vivo in the rat. J Pharmacol Exp Ther (1990) 0.84
The binding characteristics of some adrenergic beta-receptor antagonists to human serum proteins. Biochem Pharmacol (1982) 0.84
Calretinin expression as a critical component in the control of dentate gyrus long-term potentiation induction in mice. Eur J Neurosci (1998) 0.84
Contextual fear conditioning is disrupted by lesions of the subcortical, but not entorhinal, connections to the hippocampus. Exp Brain Res (2001) 0.84
Survey for positive Limulus amoebocyte lysate test in plasma from humans and common research animals. J Clin Microbiol (1978) 0.84
Promoter activity associated with the left inverted terminal repeat of the killer plasmid k1 from yeast. Biochimie (1991) 0.84
Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. J Cardiovasc Pharmacol (1993) 0.84
Cell wall component and mycotoxin moieties involved in the binding of fumonisin B1 and B2 by lactic acid bacteria. J Appl Microbiol (2009) 0.83
Establishment of a rabbit model for bovine herpesvirus type 5 neurological acute infection. Vet Microbiol (1996) 0.83
[Chronic knee instability. Technics and results of ligament plasty in sports injuries]. J Chir (Paris) (1975) 0.82
Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats. Biopharm Drug Dispos (1983) 0.81
Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice. J Pharmacol Exp Ther (1998) 0.81
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo. Neuropharmacology (1996) 0.81
Characterization of the transport of a cationic octapeptide, octreotide, in rat bile canalicular membrane: possible involvement of P-glycoprotein. Biol Pharm Bull (1998) 0.81
Reinforcement of tendons and ligaments with carbon fibers. Four years, 1300 cases. Clin Orthop Relat Res (1985) 0.80
Prevalence of antibodies to human adenovirus type 5 in Belgian cattle. Vet Rec (2001) 0.80
Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine. Life Sci (1997) 0.80
Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes. Pharmacology (1988) 0.79
Expression of a foreign KmR gene in linear killer DNA plasmids in yeast. Gene (1990) 0.79
From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics. Metabolism (1992) 0.78
Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. Aliment Pharmacol Ther (1994) 0.78
Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res (1994) 0.78
Direct evidence for the different roles of the N- and C-terminal regulatory disulfides of sorghum leaf NADP-malate dehydrogenase in its activation by reduced thioredoxin. FEBS Lett (1996) 0.78
Analysis and manipulation of target enzymes for thioredoxin control. Methods Enzymol (1995) 0.78
[Postero-internal menisco-capsular disinsertions associated with chronic instabilities of the knee caused by rupture of the anterior cruciate ligament]. Rev Chir Orthop Reparatrice Appar Mot (1984) 0.78
Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm Res (1995) 0.78
Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field. Vet Rec (2003) 0.78
Cross-sectional study of the association between pathological conditions and myxoma-virus seroprevalence in intensive rabbit farms in Europe. Prev Vet Med (2001) 0.78
Epidermal growth factor receptors in human tumors of the central nervous system. Anticancer Res (1990) 0.77
Creation of a functional promoter by rearrangement in a Kluyveromyces lactis linear plasmid. Gene (1994) 0.77
Rising plasma levels of 19-nortestosterone throughout pregnancy: determination by radioimmunoassay and validation by gas chromatography-mass spectrometry. J Clin Endocrinol Metab (1987) 0.77
Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely moving rats utilizing microdialysis. Pharm Res (1994) 0.77
Nuclear thyroid hormone receptors in human cancer tissues. Anticancer Res (1986) 0.77
Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity. Eur J Clin Pharmacol (1993) 0.77
Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro. Drug Metab Dispos (1997) 0.77
Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. J Pharmacol Exp Ther (1996) 0.77
High-performance liquid chromatographic analysis of (S)-alpha-amino-5-phosphonomethyl[1,1'-biphenyl]-3-propanoic acid (EAB 515) in brain and blood microdialysate (on-line) and in plasma ultrafiltrate of freely moving rats. J Chromatogr B Biomed Appl (1996) 0.77
Thyroid influence on the growth of hepatoma HW-165 in Wistar rats. Biomedicine (1981) 0.77